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Introduction
The wild shrub Clausena excavata Burm. f. (Family: Rutaceae) is extensively distributed in the Himalayas, China and Southeast Asia. Locally known as 'Cherek Hitam' in Malaysia and 'San Soak' in Thailand, this shrub has a strong and rather objectionable smell. It has been used in folk medicines in eastern Thailand for the treatment of cancer (Manosroi et al., 2004; Perry, 1980) . Apart from being described ethnomedically as an anti-cancer plant, it is also used to treat abdominal pain and snakebite and as a detoxification agent. Moreover, various parts of this plant are used to cure ulcer, bowel complaints, cough, headache, rhinitis, malaria and dysentery (Gimlette and Thomson, 1939; Grieve and Scora, 1980; Swarbrick, 1997; Wiart et al., 2004; Yoshida, 1996) . Several chemical constituents have been identified from C. excavata, chiefly alkaloids, coumarins and a few limonoids. Many of these constituents have been shown to be biologically active, including clausine-B, clausine-TY and clausenidin as anticancer agents (Taufiq-Yap et al., 2007; Zain and I'Zzah, 2005) ; nordentatin, clausarin, dentatin (DTN), xanthoxyletin and murrayanine as anti-bacterial agents (Ali et al., 2000; David Phillipson and Wright, 1991) ; mukonal as an anti-fungal agent (Takemura et al., 2000) ; clausene-D as an anti-platelet agent (Wu et al., 1994) ; and sansoakamine as an anti-malarial agent (Lastra-Gonzalez et al., 2005) . In addition, nordentatin, 3-formylcarbazole, mukonal, 3-methoxycarbonylcarbazole, murrayanine, 2-hydroxy-3-formyl-7-methoxycarbazole, clauszoline-J, clausenidin and xanthoxyletin have shown anti-mycobacterial activity (Sunthitikawinsakul et al., 2003) .
Because cancer is a leading health concern in society, numerous research studies into possible alternative and complementary therapies are currently being pursued. Evidence-based ethnopharmacology is one such field of study that has successfully and significantly contributed to the benefit of cancer patients. An in vitro study of clausine-B isolated from this plant found it to be active against breast, cervical and liver cancers (Zain et al., 2009) ; other plant compounds with activity against these three cancers were clausenidin, nordentatin and clausarin. Taufiq et al. furthermore reported that clausine-TY isolated from C. excavata was active against leukemia cells (Taufiq-Yap et al., 2007) . In addition, DTN has been shown to be active as a cytotoxic agent in tumour cells in vitro (Kawaii et al., 2001; Kostova, 2005) . Other flavonoids from this plant have also been identified as potential cytotoxic agents (Look et al., 1991) . This scientific evidence clearly demonstrates the potential of this traditionally used plant. The cytotoxic potential of the phytochemicals is, however, low (High IC 50 ), and there is no literature that explains the mechanism by which these chemicals induce cell death.
Thus, using a bioassay-guided approach, we aimed to extract the constituents of this plant to obtain a potential cytotoxic compound.
Materials and methods

Plant materials
The plant used in this study, C. excavata Burm. f., was collected from Pendang, Kedah, Malaysia, in February 2011. The taxonomic identification of this plant was carried out by Dr. Shamsul Khamis (a resident botanist) at the Biodiversity Unit, Institute of Bioscience, University of Putra Malaysia. A voucher specimen was deposited in the herbarium of the institute (TI-013201-CE). Roots and stem bark were cut into thin slices and dried at room temperature. The dry plant materials were ground into coarse powder with a mill grinder.
Preparation of extracts from C. excavata
Fresh stem bark (2.0 kg) and roots (2.5 kg) of C. excavata were successively extracted at room temperature (ca. 25-27 ƕ C) with analytical grade solvents of hexane, chloroform, ethyl acetate and methanol (MeOH). First, the dried plant materials were extracted with 10 L hexane in 2 large flasks (10 L), 5 L in each, for a week and filtered.
The filtrates were collected and the residues brought to dryness and extracted with 12 L chloroform, 6 L in each flask, following the same method as for hexane. The filtrates were collected and the residues brought to dryness and extracted with 13 L ethyl acetate, 6.5 L in each flask, following the same method as for hexane and chloroform.
The filtrates were then collected and the residues brought to dryness and extracted with 8 L 90% ethanol following the same method as for hexane, chloroform and ethyl acetate. 
Bioassay-guided fractionation
The eight different extracts of stem bark and root samples obtained from four different extraction solvents (hexane, chloroform, ethyl acetate and MeOH) were subjected to a cell proliferation assay. Growth inhibition pro¿les (percentage viability curves) were established, from which the IC 50 values were determined. From the results of an anti-proliferative assay, the chloroform extract of the roots of C. excavata was chosen for further purification, as it showed the best activity, with IC 50 of 10.28 ± 0.70 μg/ml (Table 2) , compared with the other extracts of both stem bark and roots. The crude chloroform extract of the roots of C. excavata (76 g) was subjected to column chromatography, which was performed on a glass column (36 x 3.5 cm) packed with silica gel (600 g) of particle size 0.04-0.06 mm. Elusion was carried out by a petroleum ether-ethyl acetate mixture of increasing polarity. Fractions of 20 ml portions were collected and combined into eight fractions on the basis of thin layer chromatography (TLC) analysis using petroleum ether-ethyl acetate or chloroform as a solvent system and vanillin/H 2 SO 4 as a spray reagent. From the results of an anti-proliferative assay, fraction 5 (3.5 g) was further purified, as this extract exhibited the lowest IC 50 value (the highest activity) among the eight fractions (Table 2) .
Centrifugal TLC (Chromatotron)
The compounds were separated on a spinning disc that holds a thin silica layer (2 mm) and a 0.5 g sample. Elution with a solvent produces concentric bands of the components, which were spun off the edge of the plate (rotor) together with the solvent.
A collection system brings the elute to a single output tube. The elusion was carried out by petroleum ether-dichloromethane mixtures of increasing polarity, from which 10 ml fractions were collected. TLC aluminum sheets precoated with silica gel 60 F 254 (0.2 mm thickness) were used to detect and monitor components present in the crude samples or fractions. These spots were visualized under UV light at 254 and 365 nm and spraying reagents were incorporated (vanillin-H 2 SO 4 , Dragendorff and FeCl 3 in MeOH). Vials exhibiting one spot were combined to give the targeted impure compound, DTN (2.96 g). DTN was then purified by washing it with a 1:20 mixture of a MetOH/petroleum ether solvent system. The solid obtained was recrystallized from the mixture solvent to give pure white needles of DTN (2.86 g). High performance liquid chromatography was run on the pure compound to validate its purity (supplementary file attached). The crystals of DTN (Fig. 1A) were then kept for further chemical and pharmacological analyses.
Identi¿cation and characterization of DTN
1 H NMR spectra were recorded on a Bruker Avance 400 spectrometer, ¹³C NMR spectra were recorded on an Ac 150 MHz instrument and direct injection mass spectra were recorded on a Finnigan MAT 31 mass spectrometer with a MATSPECO Data System. The spectral data were found to be in good agreement with the published data (Fuhrer et al., 1970; Xin et al., 2008) . The cells were maintained in RPMI-1640 medium that is supplemented with 10% Fetal Bovine Serum (FBS). Viability assay was done using MTT assay as described previously (Wahab et al., 2009 The cells were then centrifuged at 300 x g for 10 min. Supernatant was discarded and the cells were washed twice using PBS after centrifuging at 300 x g for 10 min to remove the remaining media. Ten microliters of fluorescent dyes containing AO (10 mg/ml) and PI (10 mg/ml) were added into the cellular pellet at equal volumes. (Ciapetti et al., 2002) . This assay provides a useful quantitative evaluation of apoptosis and was done in triplicates (n=3).
Colonogenic survival assay
This assay was used to measure the ability of MCF-7 cells to grow in an anchorage independent manner. Cells were assayed for the cytotoxic effects of DTN after cell survival according to the established methods of performing the clonogenic assay. Subconfluent cultures were exposed to DTN for 6 h. Then the cells were washed with PBS preheated to 37°C, trypsinized and plated in 6-well plates (100 cells/well).
After 12 days of incubation in complete culture medium, the colonies were stained with crystal violet after fixation with formaldehyde and counted manually. The results are expressed as survival fraction (n=3).
DNA fragmentation analysis
MCF-7 cells were seeded at a density 1 × 10 6 cells/ml in culture flask and Ltd., Paisley, Scotland), visualized with a UV light transilluminator, and photographed.
Caspase-3/7 and 9 activity assay
Caspase-3/7 and -9 activities were determined using the luminescence-based assay, Caspase-Glo™ 9 Assay, and Caspase-Glo™ 3/7 Assay (Promega). Cells were cultured in 96-well culture plates in 50 ȝl of RPMI 1640 supplemented with 10% FBS were incubated for 24 h and then treated with different concentrations of DTN. At the end of incubation, 100 ȝl of assay reagent was added and the plates incubated for 1 h at room temperature. Luminescence was measured using a microplate reader (Tecan Infinite M 200 PRO, Männedorf, Switzerland).
Multiple cytotoxicity assay
Cellomics Multiparameter Cytotoxicity 3 Kit (Cellomics, PA, USA) was used as described in detail previously (Mohan et al., 2012) . This kit enables simultaneous measurement in the same cell, six independent parameters that monitor cell health, including cell loss, nuclear size and morphological changes, mitochondrial membrane potential changes, cytochrome c release, and changes in cell permeability. The plates were analyzed using the ArrayScan HCS system (Cellomics, PA, USA).
Detection of NF-kB activity
The HCS was used to determine the inhibitory effects of DTN on TNF-Į-induced NF-kB activation, i.e. nuclear translocation of NF-kB. The experiments were performed according to manufacturer's instructions for the NF-kB activation kit (Cellomics, PA, USA). ArrayScan reader was used to quantify the difference between the intensity of nuclear and cytoplasmic NF-kB-associated fluorescence, reported as translocation parameter.
Image acquisition and cytometric analysis
Plates with stained cells were analyzed using the ArrayScan HCS system 
Measurement of reactive oxygen species generation
The production of intracellular ROS was measured using the 2ƍ,7ƍ- 
Determination of the level of Bcl-2 and Bax expression
The level of expression of Bcl-2 and Bax was determined by colorimetry procedures by using Human Bcl-2 (Bender Medsystems, Vienna, Austria) and Bax 
Cell cycle analysis by flow cytometry
The cell cycle phase arrest was determined by flowcytometry. MCF-7 cancer cells were plated in 25 cm 3 flasks at 1x10 6 cells/ml density and treated with DTN. At day 1 post treatment, the cells were harvested in centrifugal tubes and centrifuged at 3000 rpm phases were analyzed by ModFit LT software (Verity Software House, Topsham, ME).
Statistical analyses
Data was presented as mean ± standard deviation. Significant differences were determined by using the Student's t-test where *p < 0.05 denotes a statistically significant difference. All the samples were measured in triplicates.
Results
DTN inhibited the growth of MCF-7 cells
The cytotoxicity of DTN was studied with the MTT assay in MCF-7 and MCF-10A cells. The results are shown in Figure 1B . DTN inhibited the MCF-7 cells with an IC 50 of 6.13 ± 0.01 μg/ml (18.80 μM), whereas the IC 50 for the MCF-10A cells was 23.16 ± 1.26 μg/ml (71.04 μM).
Quantification of apoptosis using phase-contrast microscopy and acridine orange/propidium iodide double staining
Initially DTN was investigated for its apoptosis-inducing effect. Morphological changes in MCF-7 cells were observed under phase-contrast microscopy after treatment with DTN at 24, 48 and 72 h. After 24 h, clear signs of apoptosis, such as cytoplasmic shrinkage and membrane blebbing, were observed at a treatment concentration of 6 ȝg/ml. Moreover, small apoptotic bodies were seen at 48 and 72 h (Fig. 2 ). This observation of apoptosis was confirmed by fluorescence microscopy analysis.
The cells were scored under the fluorescence microscope in order to quantify viable cells and those in early apoptosis, late apoptosis and secondary necrosis. We counted 200 cells arbitrarily and differentially, together with the untreated negative control. We observed early apoptosis by means of acridine orange within the fragmented DNA with a bright green fluorescence. At the same time, control cells were observed with a green intact nuclear structure. At 24 h treatment with DTN, moderate apoptosis was seen by blebbing and nuclear chromatin condensation. Furthermore, in the late stages of apoptosis, changes such as the presence of a reddish-orange colour due to the binding of acridine orange to denatured DNA were observed after 48 h and 72 h of treatment ( Fig. 3 A-D) . The results showed that DTN generated morphological features that relate to apoptosis in a time-dependent manner. A statistically significant (p<0.05) difference was observed in the cell population during the differential scoring of treated cells (200-cell population) (Fig. 4) .
Effects of DTN on colony formation of MCF-7cells
In order to evaluate the ability of DTN to inhibit the growth of MCF-7 cells, we treated the cells with increasing concentrations of DTN (Fig. 5) . The number of colonyforming cells was reduced in a concentration-dependent manner by DTN. The cloning efficiency of MCF-7 at concentrations of 8, 16 and 25 ȝg/ml DTN was 0.073, 0.044 and 0.00, respectively, but that of untreated MCF-7 cells as a control was 0.098 (Table 3) .
No colony could be observed at a DTN concentration of 25 ȝg/ml, indicating that DTN actively inhibits the proliferation of MCF-7 cells. This result is consistent with the result of the MTT assay.
Identification of apoptotic MCF-7 cells using gel electrophoresis (laddering)
DNA laddering during apoptosis proceeds through an ordered series of stages commencing with the production of DNA fragments. DTN showed distinct DNA ladder formation with treated cells. From the figure 6, it is clear that exposure of MCF-7 cells with 8 μg/ml DTN led to evident DNA fragmentation, as indicated by the formation of a DNA ladder in the agarose gels. Meanwhile, cells treated with the Actinomycin D (positive control), which was supplied with the kit manufacturer had showed very clear ladder in the gel. In contrast, the dimethyl sulfoxide-treated control showed no evident DNA ladder. This finding was the hallmark of apoptosis induced by DTN.
Actinomycin D, which was supplied with the kit manufacturer
DTN-induced apoptosis in MCF-7 cells
To confirm the presence of apoptosis seen in the DNA ladder assay, we examined the nuclear morphological changes of MCF-7 cells by determining nuclear condensation and the fragmentation hallmark for apoptosis (Fig. 7) . Hoechst 33342 staining showed that a portion of the cells displayed nuclear condensation at all treatment concentrations of DTN. Nuclear intensity directly corresponded to apoptotic chromatin changes, including blebbing, fragmentation and condensation, as shown in Figure 8A . A concurrent increase in cell permeability was also observed (Fig. 8B ).
DTN-induced mitochondrial membrane potential (MMP) disruption and release of cytochrome c
During apoptosis, mitochondrial membrane potential is frequently disrupted due to the formation of permeability transition pores or the insertions of proapoptotic proteins, such as, Bid or Bax in the mitochondrial membrane. Therefore, we examined the effect of DTN on the MMP of MCF-7 cells using a mitochondria-specific voltagedependent dye. As shown in figure 8C , MMP was significantly reduced in cells treated with DTN (p<0.05). MCF-7 cells treated with DTN concentrations of 16 and 25 μg/ml for 24 h showed a significant reduction in fluorescence intensity (Fig. 7) , which reflected the collapse of MMP. DTN also triggered a significant translocation of cytochrome c from the mitochondria into the cytosol during apoptosis in MCF-7 cells (Fig. 7) . At 25 μg/ml, DTN triggered 4 times the release of cytochrome c compared with control (p<0.05) (Fig. 8D) .
DTN increased activity of caspase-3/7 and -9 enzymes
Since the process of apoptosis involves a cascade of proteolytic activity, which plays a central role in apoptosis via the controlled demolition of cellular architecture in response to diverse stimuli, we investigated whether DTN can activate the caspases by examining MCF-7 cells which were treated with different concentrations of DTN for 24 h.
Activity of both caspases was significantly increased with 16, 25 and 40 μg/ml DTN treatment (p<0.05) (Fig.9) .
DTN-induced cell death includes increased reactive oxygen species (ROS) formation
The generation of intracellular ROS is always associated with MMP disruption and cell apoptosis. To investigate this association, we examined the levels of ROS in MCF-7 cells treated with DTN. ROS was monitored by the oxidation-sensitive fluorescent dye 2ƍ,7ƍ-dichlorofluorescein diacetate (DCFH-DA). A concentrationdependent increase in DCF fluorescence was detected in treated cells (Fig. 10) . A significant and instant production of ROS, up to 4 times faster than that observed in the control, was detected at 16 and 25 μg/ml DTN treatments.
Levels of Bcl-2 and Bax
The levels of both mitochondrial proteins were estimated by using an ELISA kit. In this assay, Bcl-2 expression decreased significantly (p<0.05) when MCF-7 cells were treated with 8, 16 and 25 μg/ml of DTN extract after 24 h as compared with the control cells. The expression of the proapototic protein bax, however, increased significantly (p<0.05) (Fig. 11) .
DTN inhibits tumour necrosis factor alpha (TNF-Į)-induced nuclear factor-kappa B (NF-kB) nuclear translocation
We examined the role of DTN in the inhibition of activated NF-kB induced by the inflammatory cytokine, TNF-Į, by using Alexa Fluor 488-conjugated anti-NF-kB antibody. In control cells, a high NF-kB fluorescence intensity was found in the cytoplasm but only faintly in the nuclei, resulting in a negative nucleus-cytoplasm intensity difference. Cells stimulated by TNF-Į alone showed a significantly increased NF-kB fluorescence intensity in the nuclei. DTN showed significant inhibitory effects on the activation of NF-kB (Fig. 12) , at both 25 and 40 μg/ml, in a dose-dependent manner.
DTN inhibits MCF-7 cell proliferation and G0/G1 cell cycle arrest
We performed an experiment to evaluate the effect of DTN on the DNA content of MCF-7 cells by cell cycle phase distribution (G0, G1, S, G2 and M) after treatment for 24 h (Fig. 13) . Results demonstrated that DTN arrested cell cycle progression at the G0/G1 phase (p<0.05). Results shown in Figure 14 indicate that there was a significant G0/G1
phase arrest in a concentration-dependent manner, accounting for 25%, 30%, 50%, 53% and 48% of cells after 8, 16, 25, 40 and 50 μg/ml treatment, respectively, for 24 h (p<0.05). Both S and G2/M phase cells decreased as the treatment concentration increased.
Discussion
In the present study, we demonstrated for the first time that DTN, a purified compound from the root bark of C. excavata (which has been used as a traditional medicinal plant for cancer in Thailand), induces apoptosis in human breast cancer cells selectively via mitochondria-dependent activation of the caspase cascade, with significant inhibition of NF-kB and a G0/G1 cell cycle arrest.
Extraction of the roots and stem bark of C. excavata resulted in eight extracts that were subjected to cytotoxicity screening. The results obtained then guided us to select the chloroform extract of stem bark for further purification. Chromatotron chromatography of the extract yielded eight fractions. Fraction 5 (CH/F5) was selected for purification and further isolation, which resulted in the isolation of DTN. Since it is important for an anticancer agent to exhibit cytotoxicity that is selective for cancer cells (Trachootham et al., 2006) , the effect was studied on normal cells. The results showed an IC 50 of 23.16 ± 1.26 μg/ml for MCF-10A (non-tumorous breast cells), compared with an IC 50 of 6.13 ± 0.01 μg/ml for MCF-7 cells. Because the cytotoxicity was found to be selective, we proceeded with the study of the cytotoxicity mechanism.
Since apoptosis is actively involved in cellular homeostasis and an active physiological process resulting in cellular self-destruction, it has been recognized as a novel strategy for the identification of anticancer drugs (Fesik, 2005) . This mode of cell death is a strictly controlled process, characterized by chromatin condensation, DNA fragmentation, membrane blebbing, cell shrinkage and compartmentalization of the dead cells into apoptotic bodies, along with various biochemical changes (Mohan et al., 2010) .
In the present study, acridine orange/propidium iodide double staining and nuclear staining with Hoechst dyes in DTN-treated MCF-7 cells displayed early as well as late phases of apoptosis. A DNA laddering assay further allowed us to examine this apoptotic behaviour induced by DTN. DNA fragmentation is a key feature of apoptosis and one of the easily measured features of apoptotic cells (Cohen et al., 1992) . In this study, a time-related trend of increased DNA fragmentation that implicated apoptosis was observed in treated MCF-7 cells using gel electrophoresis analysis. In addition, the number of colony-forming cells was reduced in a concentration-dependent manner by DTN treatment, further suggesting the involvement of apoptosis.
Even though apoptosis involves both intrinsic and extrinsic pathways, tumours arise more frequently through the intrinsic pathway than the extrinsic pathway because of its sensitivity (Mohan et al., 2010) . Since mitochondria have the ability to activate the cellular apoptotic program directly, they are considered the major cellular component in the intrinsic way of apoptosis (Susin et al., 1999) . Mitochondria release intracellular cytochrome c, a heme protein, to the cytoplasm, which interacts with dATP and apoptotic protease activating factor 1 (Apaf-1) in the apoptosome complex and subsequently activates procaspase-9 to form active caspase-9, leading to the activation of the executioner caspase-3 (Marsden et al., 2002) . In order to initiate this process, MMP must be reduced. Fluorescence-based high content screening analysis revealed that DTN acts on the mitochondria, causing the loss of MMP. Moreover, the release of cytochrome c concurrently increases. In support of these findings, we observed that both caspase-3/7 and 9 were significantly increased upon DTN treatment. Additionally, DTN treatment led to a significant generation of ROS, up to 4 times that of the control. Much evidence shows an association between mitochondrial-derived ROS and later mitochondrial events, leading to caspase cascades (Simon et al., 2000; Skulachev, 1996) .
In the intrinsic pathway, apoptosis by chemotherapeutic agents is controlled by the ratio of Bcl-2:Bax proteins in the mitochondria (Korsmeyer et al., 1993) . The proapoptotic activity of Bax and the anti-apoptotic protein, Bcl-2, work together. Bax moves to the mitochondria and triggers a disastrous alteration of mitochondrial function by formation of mitochondrial membrane transition pores and a reduction in MMP, which leads to the potentiation of apoptosis induced by chemotherapeutic agents (Zamzami and Kroemer, 2003) . Our data had previously shown this dysregulation of MMP. The results obtained suggest that treatment of MCF-7 cells cause the down-regulation in Bcl-2 and significantly up-regulate the expression of Bax. Generally, Bcl-2 family proteins will inhibit the proapotoic activity of Bax (Gross et al., 1999) . Therefore, DTN acts by balancing the ratio of Bax:Bcl-2; the increase of Bax protein in MCF-7 cells seems to contribute to the apoptotic effect. Along with Bax and Bcl-2 family members, NF-kB has also been considered as an apoptosis inhibitor (Yang et al., 2004) . Thus, apoptosis can be induced once the activity of NF-kB is repressed. We have demonstrated here that the TNF-Į-induced NF-kB translocation from cytoplasm to nucleus can be prevented by DTN, which suggests the involvement of an NF-kB inhibition mechanism in apoptosis.
Phytochemicals that function as cell-cycle modulators are gaining widespread attention due to the recent evidence of concomitant involvement of apoptosis and cell cycle inhibition (Ding et al., 2011; Wang et al., 2011) . In many instances, irregularities in cell cycle regulation are associated with cancer progression (Park and Lee, 2003) . Thus, flow cytometry analysis was performed to analyse the various cell cycle checkpoints.
DTN induced G0/G1 phase cell cycle arrest in treated MCF-7 cells. Moreover, the slight increase in the sub G1 phase confirms the apoptosis findings.
In conclusion, the bioassay-guided approach to the processing of C. excavata led to the isolation and purification of DTN. This compound was able to kill the MCF-7 cells selectively and induce apoptosis via the mitochondrial pathway. Furthermore, a significant inhibition of NF-kB and a G0/G1 cell cycle checkpoint arrest were also found.
The cytotoxic results obtained from our work represent new insight into the traditional use of C. excavata as an anti-cancer plant. DTN may thus warrant further in vivo studies so as to develop it as a successful natural compound that could be used for the treatment in breast cancer. In addition, C. excavate could be exploited for novel phytochemical isolation '*' Indicates a significant difference p < 0.05. 
